EcoDrugPlus

N-Acetylated-Alpha-Linked Acidic Dipeptidase 2-Like

Ensembl ID : ENSCMIG00000013613
Gene Symbol: LOC103184309
4 Cross references
340 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSCMIG00000013715
Gene Symbol: NOX4
3 Cross references
150 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSCMIG00000010165
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:

P-Selectin-Like

Ensembl ID : ENSCMIG00000016729
Gene Symbol: LOC103179971
3 Cross references
126 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSCMIG00000010851
Gene Symbol: LOC103184463
4 Cross references
182 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCMIG00000015880
Gene Symbol: PIM3
3 Cross references
197 Possible Orthologues:

Rac-Alpha Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSCMIG00000001663
Gene Symbol: LOC103174353
3 Cross references
255 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCMIG00000010901
Gene Symbol: RAF1
3 Cross references
225 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSCMIG00000015932
Gene Symbol: ROCK1
4 Cross references
212 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSCMIG00000010304
Gene Symbol: ROCK2
4 Cross references
302 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSCMIG00000007863
Gene Symbol: TEK
4 Cross references
166 Possible Orthologues:

Tgf-Beta Receptor Type-1-Like

Ensembl ID : ENSCMIG00000015638
Gene Symbol: LOC103181552
4 Cross references
236 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).